ER OROS paliperidone

DRUG6 trials

Sponsors

Janssen Pharmaceutical K.K., Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions

Renal ImpairmentSchizophrenia

Phase 1

A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function

CompletedNCT00791401

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Renal Impairment, Schizophrenia

Start: 2004-04-30End: 2005-02-28Updated: 2011-06-13

A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone

CompletedNCT00796835

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Schizophrenia

Start: 2004-07-31End: 2004-10-31Updated: 2011-05-24

A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone

CompletedNCT00892541

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Schizophrenia

Start: 2004-10-31End: 2004-11-30Updated: 2011-06-08

A Bioequivalence Study of 15 mg ER OROS Paliperidone

CompletedNCT00892489

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Schizophrenia

Start: 2004-07-31End: 2004-12-31Updated: 2011-06-08

A Study of the Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese Volunteers

CompletedNCT00892320

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Schizophrenia

Start: 2004-03-31End: 2004-05-31Updated: 2011-06-08

Phase 3

A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia

CompletedNCT00396565

Janssen Pharmaceutical K.K.Schizophrenia

Start: 2006-07-31End: 2007-11-30Updated: 2014-04-29